Leading Healthcare Facility in South Korea Helps Advance the Practice of MRI-Guided Radiation Therapy Through Research, Protocols, and Publications CLEVELAND , Dec. 22, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the clinical team at Seoul National University Hospital
Leading Clinical Training Hospital Aims to Begin MRIdian Patient Treatments in 2021 CLEVELAND , Dec. 21, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Catharina Hospital in Eindhoven, Netherlands , also known as Catharina Ziekenhuis, has purchased a MRIdian ® Linac
CLEVELAND , Nov. 23, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference . From November 23 to December 3, 2020 , a fireside chat recording will be available for registered attendees via the Piper
Amsterdam UMC reaches treatment milestone while establishing key clinical evidence in tough-to-treat cancer including pancreas, prostate, lung, liver, and kidney CLEVELAND , Nov. 12, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the clinical team at Amsterdam University
Universitair Ziekenhuis Brussels in Belgium Aims to Begin MRIdian Patient Treatments in 2021 CLEVELAND , Nov. 10, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Universitair Ziekenhuis Brussels has purchased a MRIdian ® Linac MRI-Guided Therapy System, a cutting-edge
CLEVELAND , Nov. 5, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the third quarter ended September 30, 2020 . Third Quarter 2020 Highlights: Total revenue of $10.1 million , primarily from one revenue unit, compared to $20.9 million ,
Nearly 40 MRIdian-focused presentations will be part of the ASTRO Scientific Sessions CLEVELAND , Oct. 21, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian® Linac MRI-guided radiation therapy system will be featured at the 2020 Annual Meeting of the
CLEVELAND , Oct. 15, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its third quarter 2020 financial results. ViewRay will hold a conference call to discuss results on Thursday, November 5, 2020 at 4:30 p.m. ET / 1:30 p.m. PT .
MRIdian to Bring Benefits of MRI-Guided Radiation Therapy to Veterans Throughout Ohio and the Surrounding Region CLEVELAND , Oct. 14, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the Louis Stokes Cleveland VA Medical Center in Cleveland, Ohio has purchased the MRIdian ®
CLEVELAND , Oct. 1, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced that the Company will host a virtual physician-led informational discussion for investors and analysts during the 2020 American Society of Radiation Oncology (ASTRO) Annual Meeting.
Brings Benefits of MRI-Guided Radiation Therapy Closer to Home for Cancer Patients in Korea CLEVELAND , Sept. 24, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Chungnam National University Sejong Hospital in Sejong, South Korea has begun patient treatments with the MRIdian
CLEVELAND , Sept. 4, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in three upcoming virtual investor conferences. Event : Cantor Virtual Global Healthcare Conference Format: Virtual 1x1 Meetings Date:
MRI-Guided Radiation Therapy Brings Cutting-Edge Cancer Treatment to Patients Around the World CLEVELAND , Sept. 1, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that 10,000 patients have been treated to date using the company's MRIdian ® MRI-Guided Radiation Therapy System,
ViewRay, the GenesisCare Foundation and the Pancreatic Cancer Research Fund Work Together to Provide MRIdian Radiation Therapy at No Cost to NHS Pancreatic Cancer Patients CLEVELAND , Aug. 27, 2020 /PRNewswire/ --– ViewRay, Inc. (Nasdaq: VRAY) announced today that the GenesisCare Foundation's
Brings Benefits of MRI-Guided Radiation Therapy Closer to Home for Cancer Patients in New England CLEVELAND , Aug. 13, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Dartmouth-Hitchcock Health in New Hampshire has begun patient treatments with the MRIdian ® MRI-Guided
First MR-Linac in Taiwan Provides Patients Access to MR-Guided Radiation Therapy CLEVELAND , Aug. 5, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH) in Kaohsiung City, Taiwan has begun patient treatments with the
CLEVELAND , July 30, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the second quarter ended June 30, 2020 . Second Quarter 2020 Highlights: Total revenue of $14.2 million , primarily from two revenue units, compared to $30.2 million , primarily from
CLEVELAND , July 13, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second quarter 2020 financial results. ViewRay will hold a conference call to discuss results on Thursday, July 30, 2020 at 4:30 p.m. ET / 1:30 p.m. PT .
Study Shows Low Incidence of Toxicity Using Stereotactic Body Radiation Therapy (SBRT) While Reducing Potential Complications Associated with Implanted Markers CLEVELAND , June 23, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today the publication by the European Urology Oncology
CLEVELAND , June 3, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today grants of stock options and restricted stock units to Zach Stassen , Chief Financial Officer for the company. These awards were granted as an inducement material to entering into employment with ViewRay , in
